Immunological Studies on Antibodies against Heat Shock Proteins in Autoimmune Diseases by Tasneem, Subia
IMMUNOLOGICAL STUDIES ON ANTIBODIES 
AGAINST HEAT SHOCK PROTEINS IN 
AUTOIMMUNE DISEASES 
DISSERTATION ^ 
SUBMITTED IN PARTIAL FULFILMENT OF 
THE REQUIREMENTS FOR THE 
AWARD OF THE DEGREE OF 
M^ittx of $|)iIoj3iopI)p 
IN 
BIOCHEMISTRY 
BY t '# - M K / 
/ 
Dated *. .M*.*.. ^ , . - -' " \ ^jf 
Approved: ^ ^ ^ V ^ > ' ^ . ^ . / 
Prof. Rashid AH (Supervisor) 
DEPARTMENT OF BIOCHEMISTRY 
FACULTY OF MEDICINE 
JAWAHARLAL NEHRU MEDICAL COLLEGE 
ALIGARH MUSLIM UNIVERSITY 
ALIGARH (INDIA) 
1995 
DS2636 
J., ^^^5^M 
2 ^ FEB 1996 r.~, 
Fed In Comi^mai 
• - > ^ 

CERTIFICATE 
We certify that the work presented in the following 
pages has been carried out under our supervision by 
Ms. Siibia Tasneem and it is suitable for the award of M.Phil 
degree in Biochemistry of the Aligarh Muslim University, 
Aligarh. 
(Najmul Islam) 
Lecturer 
Department of Biochemistry 
Faculty of Medicine 
Aligarh Muslim University 
Aligarh 202 002 
(Rashid All)' 
Professor & Chairman 
Department of Biochemistry 
Faculty of Medicine 
Aligarh Muslim University 
Aligarh 202 002 
ACKNOWLEDGEMENT 
I owe a debt of gratitude to my supervisor Prof. Rashid 
All for his generous time and expertise, without which the 
present work would have been difficult to accomplish. I am 
particularly grateful to him for his superb guidance, 
stimulating discussion, encouragement and the facilities 
provided during the course of this work. 
I feel deeply indebted and grateful to my co-supervisor 
Dr. Najmul Islam for his encouragement ana ideal 
suggestions. He has been a great source of personal and 
professional inspiration. 
I am also thankful to Dr. Asif Ali and Dr. Khursheed 
Alam for timely suggestions. 
I wish to thank my seniors Mr. Moinuddin, Mr. B.T. 
Ashok and Mrs. Sadia Arjumand for their kind support and day 
to day discussion. 
I owe special mention of thanks to my colleagues Mr. 
Ghulam Waris, Mr. Deepak. K. Garg, Ms Nabiha Yusuf, Mrs. 
Jabeen Ahmad, Mrs. Talat Y. Shafiq and Mrs. Shaheen Khatoon 
for their warm and friendly cooperation. 
I wish to express special thanks to my friends Humra, 
Humaira, Saquib, Ghazala and my cousins Rana, Saud, Nasheet 
and Sultan for their love and cooperation. 
Cooperation of Lab Assisstants M/s Sabu Khan, Islam, 
Shabbir and Ashfaq Ali is highly appreciated, thanks are 
also due to non-teaching staff of the Department. 
Finally I am thankful to Md. Zulquernain for typing. 
i . \ -6 K :-. < •//'••''If 
(SUBIA TASNEEM) 
C O M T B M T S 
PAGE 
V l l l 
ABSTRACT i 
LIST OF FIGURES ^^ 
LIST OF TABLES 
ABBREVIATIONS 
1. INTRODUCTION 1 
2. EXPERIMENTAL 
A. MATERIALS 
B. METHODS 
3. RESULTS 4 2 
4. DISCUSSION 6 7 
5. REFERENCES 7 3 
20 
21 
ABSTRACT 
Stress or heat shock proteins are major immune 
targets in broad spectrum of infectious diseases. Of 
particular interest to immunologist and rheumatologist is 
the convergence of data in several fields that suggests 
that stress proteins in microorganism, commonly infecting 
humans, may be a trigger of humoral and cellular autoimmune 
responses and consequent overt autoimmune disease 
expression. The stress proteins of Mycobacterium 
tuberculosis and other bacteria are close homologues to 
that of mammals and may be involved in the pathogenesis of 
autoimmune diseases. The capacity of stress proteins to 
bind to multiple proteins and nucleic acids that have been 
damaged by cell stress or infection may result in the 
formation of highly immunogenic particles that drive the 
immune system to produce the marker autoantibodies and 
linked sets of autoantibodies characteristic of SLE and 
other systemic autoimmune diseases. 
Many attempts have been made to identify the antigens 
(self/non-self) responsible for the autoantibody production 
crossreactive with normal constitutents of human cells. The 
possible involvement of mycobacterial heat shock proteins 
in the autoantibody production have been indicated but 
their role in its pathogenesis is not yet clear. 
In the present study attempts have been made to probe 
the binding of SLE autoantibodies against intracellular 
protein antigen(s)/heat shock proteins of Mycobacterium 
tuberculosis (Hj^Rv). The intracellular protein antigens 
of Mycobacterium tuberculosis were isolated. The immuno-
crossreactivity of SLE autoantibodies against mycobacterial 
cellular protein antigens as well as 70 kD heat shock 
protein was probed by ELISA and Western blot assay. 
Furthermore, their specificity was ascertained by 
competition inhibition ELISA. Inhibition results revealed 
a greater magnitude of binding for SLE autoantibodies with 
intracellular mycobacterial heat shock proteins as 
compared with native DNA. The specificity of anti-DNA 
antibodies as revealed by inhibition ELISA, was found to be 
in the order of MTSE > ssDNA > ds DNA > RNA. 
70 kD heat shock protein is an immunodominant antigen 
of Mycobacterium tuberculosis. A large portion of the 
immune response to infecting mycobacteria appears to be 
directed at two particular protiens 70 kD, and 65 kD. Hsp 
70 was thus isolated by electroeluting the 70 kD band 
from an electrophoresed 5-20% gradient SDS-polyacrylamide 
gel. The interaction of hsp 70 kD was probed with Protein 
A- Sepharose isolated SLE igG, where a binding of high 
magnitude was observed. Western blot assay also exhibited 
a strong recognition of immunoaffinity purified SLE IgG 
(anti-DNA antibodies) by the 70 kDa heat shock proteins. 
The retention of cross reactivity of autoantibodies with 
hsp 70 kD after immunoaffinity purification further 
augments the idea of an alternate antigen for the 
induction of autoantibodies cross reactive with native DNA. 
Thus, the possible involvement of mycobacterial antigens 
(hsp or non hsp) in SLE autoantibody induction can be 
inferred from the present studies. 
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When the immune response against microorganisms are 
analysed, most of the protein antigens involved, of 
different pathogens, are found to belong to heat shock 
protein (hsp) families. The ubiquitous distribution of hsp 
and their high sequence conservation pose interesting 
challenges to the immune system. On one hand, the 
omnipresence of epitopes shared by all pathogens may provide 
the immune system with a universal signal for infection. 
Furthermore, the expression of hsp by transformed, or 
otherwise stressed cells could facilitate their rapid and 
efficient identification through a common mechanism. On the 
other hand, epitopes shared by the predator and the host 
may also furnish a link between infection and autoimmunity, 
which under unfavourable conditions, may trigger 
deleterious responses (Kaufmann, 1990). 
Cultured cells or whole organism are found to respond 
to a wide spectrum of stresses, which includes heat shock, 
nutrient deprivation, oxygen radicals, metabolic disruption 
etc., by synthesizing a small group of proteins namely, the 
stress proteins. The best studied of these stresses is the 
heat shock (Lindquist, 1986; Lindquist and Craig, 1988; 
Welch, 1989) where a sudden increase in temperature induces 
increased synthesis of shock proteins, hence the name heat 
shock proteins. 
The stress proteins appear to provide the cell with the 
protection during or after recovery from the environmental 
insults. In all organisms the induction of hsp is 
remarkably rapid and intense in keeping with the notion 
that it is an emergency response. There is a striking 
relationship between the induction temperature and the 
organism's environment. In different organisms the 
response is induced at different temperatures and each 
organism is expected to cope with such temperature in its 
natural environment. As in fruit fly Drosophila 
melanoqaster. induction occurs between 33-37°C which is the 
common temperature on warm summer days (Lindquist, 1980). 
In thermophilic bacteria growing at 50°C the proteins are 
induced when temperatures are raised to 60°C (Daniel et 
al. , 1984) and in mammals they are induced at fever 
temperature (Li and Laszlo, 1985). 
The heat shock response is the most highly conserved 
genetic system known existing in every organism in which it 
has been sought from plants to animals. Thus, heat shock 
proteins are remarkable in their evolutionary 
conservation (Lindquist and Craig, 1988; Garsia et al., 
1989; Hickey et al., 1989; Jindal et al., 1989). Stress 
protein families are also composed of proteins that are 
related to stress proteins in sequence but whose levels 
are not altered by stress. 
The exact mechanism by which the cell recognizes a 
change in its environmental circumstances and activates the 
stress response is still unclear. One possible way which is 
shared by many treatment/ agents inducing a response is 
their ability to promote protein denaturation and / or 
aggregation (Ananthan et al., 1986; Edington et al. , 
1989). Whether this is the only possible mechanism for the 
initiation of response remains questionable. Different 
changes take place in cells after stress. After heat shock, 
an arrest in the cell cycle and a cessation of most 
activities involved with cellular proliferation (Westra and 
Dewey, 1971; Zeuthen, 1971) changes in plasma membrane 
mediated events, which include-
(a) alteration in the activities of Na'^ /K'^  ATPase (Yi, 
1979; Burden and Cutmore, 1982; Anderson and 
Hahn,1985). 
(b) decrease in insulin and epidermal growth factor binding 
activities (Calderwood and Hahn,1983 ). 
(c) rapid decrease in intracellular pH (Weitzel et 
al.,1985; Drummond et al.,1986 ). Besides these, 
morphological alterations have also been described in 
mammalian cells following heat shock treatment (Welch 
and Suhan, 1985; Yost and Lindquist,1986; Welch and 
Suhan,i986; Arrigo et al. , 1988). 
Types of Heat Shock Proteins 
A variety of hsp families have been discovered which 
includes hsp 90, hsp 70, hsp 60 and other small molecular 
weight hsp families. Each heat shock protein^ is named 
according to its approximate mass in thousands of daltons. 
Hsp 90 Feunily 
Members of this family range in size from 83 to 90 kD. 
Sequence analysis of the cloned genes of hsp 90 family 
demonstrates that the proteins are highly conserved. In most 
of the mammalian cells, the hsp 90 are abundant at normal 
temperature and are further induced by heat { Lai et al., 
1984; van Bergen en Henegouwen et al., 1987).In P. 
melanogaster, there appears to be only one gene in this 
family, hsp 83. In vertebrates, one gene in this family has 
been found to be encoding a signal sequence to transport the 
protein across the endoplasmic reticulum. The other members 
of the vertebrate family appears to be abundant at normal 
temperature. Within eukaryotes, members of this family 
display sequence homology. The E_^  coli shows 36% identity 
with D_^  melanogaster hsp 83. A tumour specific antigen, 
Meth. A has been identified as hsp 90 (Ullrich et al., 1986) 
localized atleast partly to the cell surface (Srivastava and 
Maki, 1991) . 
No enzymatic functions have been described for these 
proteins, although they have been shown to interact with 
protein kinases and steroid receptors (Kulloma et al., 1986) 
and may play some role in transport or regulation of these 
proteins (Langer and Neupert, 1991). The hsp 90 proteins of 
three parasites, Trypanosoma cruzi. Schistosoma mansoni and 
Plasmodium falciparum have been reported to be antigenic. 
No bacterial antigens have been described with homology to 
members of this family. 
Evidence is emerging which suggests that members of the 
hsp 90 class act as molecular chaperones in the mechanism of 
signal transduction by steroid receptor. In the absence of 
steroid hormones, the steroid receptor is bound to hsp 90 
and is unable to activate transcription of steroid 
controlled genes. On the contrary, supplementation of 
steroid hormone displaces the bound hsp 90 and produces a 
receptor capable of activating transcription (Ellis, 1991). 
Hsp 70 Family 
This is the most highly conserved and abundant heat 
shock protein family (Bienz, 1984; Hunt et al., 1985). Hsp 
70 of most if not all eukaryotes, is a member of multigene 
family, whose genes are under a variety of physiological 
conditions. The amino acid sequence of the human hsp 70 has 
50% homology with that of E^ coli and 73% identity with that 
of Drosophila hsp 70. The sequence identity is greater at 
amino terminal region of the protein which has been 
suggested to have a conserved ATPase activity. Some of these 
proteins are constitutively expressed while some of these 
are heat inducible and some are glucose regulated (grp 78). 
These proteins can be found during heat shock in the 
nucleus, in cytoplasm after heat shock and in endoplasmic 
reticulum (Velazquez and Lindquist, 1984). Members of hsp 70 
family have acidic isoelectric points and similar tryptic 
peptide patterns in all species examined (Lindquist, 1986). 
The mammalian proteins bind ATP very tightly, a property 
that has recently been exploited to purify them (Welch et 
al., 1985). 
dnak gene in E_^  coli encodes a protein that is related 
to hsp 70 of eukaryotes (Bardwell and Craig, 1984). Dnak is 
50% identical in amino acid sequence to hsp 70 of 
eukaryotes. This gene is identified as host gene, necessary 
for lambda DNA replication. The mycobacterial members of 
this family are highly homologous to each other and to 
members of the hsp 70 family (Young et al., 1988; Garsia et 
al. , 1989). An immunoreactive 70 kD antigen has been 
identified in M^ leprae. M. tuberculosis and M^ bovis 
(Britton et al., 1986; Watson, 1989). Four members of the 
human hsp 70 family have been identified, of which hsp 70 is 
the major heat shock protein (Watowich and Morimoto,1988). 
Hsp 60 Family 
Hsp 60 proteins have been extensively characterized in 
bacteria {E^ coli) and recently their eukaryotic homologues 
have been identified (Jindal et al.,1989; Mizzen et al. , 
1989). The amino acid sequence of hsp 60 has been found to 
be highly conserved between bacteria and human. The sequence 
identity is found to be in the range of 50 - 60%. Highly 
immunoreactive proteins of M^ tuberculosis and M^ bovis BCG 
are the mycobacterial counterparts to common antigens and 
that these antigens are homologous to E_^  coli GroEL heat 
shock protein (Shinnick et al., 1988; Thole et al., 1988; 
Young et al., 1988). 65 kD antigen is one of the major 
immunoreactive proteins of the mycobacteria. This antigen 
contains epitopes that are unique to a given mycobacterial 
species as well as epitopes that are common various species 
of mycobacteria (Gillis and Buchanan, 1982; Engers et al. , 
1985 and 1986; Gillis et al., 1985). 
In addition to the shared epitopes, these proteins also 
display common structural and immunological features. The 
features are - (i) they can be isolated as homomultimers of 
250 - 900 kD composed of approximately 60 kD sub-units in 
tubercle bacilli (ii) they contain species - specific, 
genus - specific as well as cross - reactive epitopes (iii) 
they can be either located in the cytoplasm or exposed to 
the cell surface depending on particular species within the 
genus examined (iv) they are major immunogens and antigens 
during infection with the corresponding bacteria (Hoiby, 
1975; Sompolinsky et al., 1980a and b; deBruyn et al., 1987; 
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Thole et al., 1987). Atleast four regions of more than ten 
amino acids in length are found to be identical in man and 
mycobacteria. 
Small Hsp Feunily 
This family belongs to a very diverse group. Different 
organisms have different numbers of small hsp family. The 
molecular weight ranges from 14 to 30 kD (Lindquist,1986; 
Lindquist and Craig, 1988). Though they are divergent in 
sequence, they are conserved in their stuctural properties. 
In Drosophila, the members of this family includes hsp 
22,23,26 and 28. The 18 kD antigen of M_^ leprae appears to 
be a good T-cell immunogen and antigen in individuals with 
killed M. leprae vaccine (Dockrell et al., 1989) . 
GroES Family 
In many bacteria including E_^  coli. the heat shock 
operon expressing GroEL/hsp 60 also contains a 10 kD protein 
called GroES (Hemmingson et al., 1988), while in eukaryotes, 
hsp 60 homologues are not a part of operon and that the 
GroES homologues have not been described (Jindal et al., 
1989). In mycobacteria, the GroES homologue is antigenic. 
Functions of Heat Shock Proteins 
The heat shock proteins are found to perform a variety 
of functions. Recent studies on heat shock proteins support 
the notion that these proteins act as molecular chaperones. 
There is evidence that these proteins can interact with 
polypeptide during a variety of assembly processes in such a 
way as to prevent the formation of non-functional 
structures. Heat shock proteins not only mediate assembly 
processes but also promote the disassembly of proteins that 
have been damaged as a result of stress. Heat shock proteins 
bind to interactive surfaces that are exposed by stress, 
followed by ATP mediated release, which triggers 
conformational change in the denatured protein that favour 
correct reassembly. 
These proteins possess weak ATPase activity. The amino 
terminal part of hsp 70 harbors the ATP binding site and the 
ATPase activity. Chappel et al (1987) suggested the term 
ATPase core for this domain. Hsp 70 is found to be involved 
in the post translational translocation of proteins across 
the membranes. The prokaryotic member of hsp 60 family GroEL 
protein is found to be involved in the head assembly of 
phage A (Friedman et al., 1984) and tail assembly of T^ 
(Tilly and Georgopoulos, 1982) as well as in T^ head 
assembly (Georgopoulos et al., 1972). 
Stress proteins have been known to bind a number of 
different molecules. For example, hsp 90 has been found to 
interact with steroid hormone receptor, with viral and 
cellular kinases and with actin and tubulin. Members of the 
hsp 70 family bind to DNA duplication complexes,clathrin 
baskets, the cellular tumor antigen p^ -^  and immunoglobulin 
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heavy chain. 
In eukaryotic cells, these proteins can be induced in 
vitro following infection by diverse viruses including by 
paramyxoviruses (Peluso, 1978) and adenoviruses (Nevins et 
al., 1982). Some stress proteins including hsp 90 and hsp 70 
have been found to accumulate abnormally high in transformed 
cells (Bensuade, 1983; Macnab et al., 1985). 
Inmunoreactivity of Heat Shock Proteins 
The heat shock proteins are found to be the target of 
immune response in many bacterial and non-bacterial 
infection. The possible explanation for this includes -
(a) hsp are abundant cellular proteins 
(b) have conserved epitopes that may prime the host for an 
immune respose to these proteins 
(c) may be preferentially processed for presentation due to 
either structural or functional features. 
Regarding their abundance, hsp's are found to 
accumulate to even higher levels in bacteria undergoing 
stress. Hsp 70, 60 and GroES account for more than 15% of 
the total cell protein in heat shocked cells (Neidhart et 
al., 1984). Mycobacteria grown in zinc deficient media, the 
hsp 60 accounts for around 9% of the total cell proteins 
(deBruyn et al., 1987). It is not only the change in 
temperature that occurs upon infection which induces protein 
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synthesis, other factors may also stimulate production of 
heat shock proteins. It is the stress that is inherent 
inside the lysosome of macrophage that might help to induce 
the synthesis of these proteins to high levels. 
Immunological priming 
Due to their conserved nature, it is possible that the 
infection by one pathogen might prime the host for an immune 
response against a second pathogen. This suggests that the 
immune response should be directed primarily against 
conserved epitopes. But this is not the case, as is found 
that the humoral immune response to the heat shock proteins 
is directed predominantly towards non-conserved epitopes 
(Newport et al., 1988). On the other hand, the T- cell that 
recognize either conserved epitopes of the mycobacterial hsp 
60 or hsp 10 homologues can be readily isolated (Young, 
1990). Thus, the heat shock proteins of pathogenic 
microorganism can elicit humoral and cellular immune respose 
to epitopes that are shared with their host. Such 
immunoreactivity could play important roles in pathogenicity 
and autoimmune consequences of infections. 
Structural and functional considerations 
Some members of the hsp 70, 90 and 60 families are 
found to be surface accessible as is seen in certain cells 
undergoing heat shock or other stresses. They express heat 
shock proteins on their surfaces or secrete them (deBruyn et 
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al., 1987; Jarjour et al., 1989; Koga et al., 1989). 
Perhaps, because of these structural features hsp can be 
efficiently processed and presented on the macrophage 
surfaces and hence becomes readily available for interaction 
with other components of the immune system. Presentation 
might also be facilitated by the ability of hsp 70 and hsp 
60 to bind to denatured proteins and perhaps a pathogen's 
heat shock protein could be *coprocessed' along with other 
proteins and thereby increase the likelihood of a heat shock 
protein being presented by the macrophage. Thus the 
structural and functional features of the heat shock 
proteins make them particularly favourable candidates for 
processing and presentation to the immune system and hence 
potential immunogen. 
Autoinmiune Diseases and Hsp 
The immune system has tremendous discrimination 
potential of self and non-self. However, thiL' enormous 
recognition potential includes possible interaction with 
self components, some of which appear to be essential for 
the regulation of the immune functions, (Jerne, 1974), 
whereas other can be pathogenic particularly if expressed 
at high level, leading to autoimmune diseases. 
Many theories have been proposed to explain the 
origin of autoimmune responses. For example, it has been 
postulated that immune responses directed against host 
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antigen could result from genetic predisposition, random 
B-cell activity from host and foreign antigen or 
modification of host protein as a consequence of infection 
and drug administration. It is now apparent that normal 
immune system indeed have the capacity to produce 
antibodies to a variety of self antigens. This new 
orientation of thinking about autoimmunity raises many 
tantalizing questions whose answers can only be 
speculated. 
Among the various autoimmune diseases, systemic 
lupus erythematosus (SLE) is a prototype autoimmune 
disease of unknown etiology and characterized by the 
presence of heterogenous population of circulating 
antibodies of intracellular proteins and nucleic acids. 
Stress proteins (hsp), are major immune targets in 
broad spectrum of infectious diseases and have extremely 
close homologues in man. Infection entails * stress' for 
both the microorganism as well as the host, therefore, it 
would appear to be an ideal stimulus for the emergence 
of autoreactive T-cells and B-cell reponses against host 
stress proteins. 
Different autoimmune diseases are associated with 
humoral responses to self hsp. There are also evidences 
linking mycobacterial infection with humoral 
autoimmunity (Shoenfeld and Isenberg, 1988). Hyper-
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gammaglobulinemia is found to be associated with active 
tuberculosis, and tubercle bacilli are extremely potent 
adjuvants for induction of polyclonal B-cell activation. 
Patients with pulmonary tuberculosis are found to develop 
rheum.atoid factor and many of the same antinuclear 
antibodies characteristics of patient with SLE. The 
behaviour of hsp 70 and ubiquitin in the cell raises the 
possibility that stress proteins may be key ingredient in 
the 'immunogenic particle' concept (Tan et al., 1988) of 
the origin of antinuclear and other antibodies , as has 
been suggested previously (Muller et al., 1988; Inque, 
1989) . 
Thus, hsp 70 associates itself with proteins in the 
nucleus and nucleolus in a cell cycle dependent fashion 
(Milarski et al., 1989) and migrates to different cell 
compartmc it and bind to a variety of nuclear cytoplasmic 
protein in various infected cells (Nevins, 1982; Welch et 
al., 1985; La Thangue and Lachmann, 1988; White et al., 
1988; Pallas et al., 1989; Sawai and Butel, 1989; Welch 
and Suhan, 1989). Also because stress proteins of 
bacteria are homologous with that of host, thus there 
exist the possibility in genetically susceptible 
individual for a constant risk of autoimmune disease 
development due to the failure of mechanism for 
self/nonself discrimination through molecular mimicry 
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(Oldstone, 1987) . That these prote ns actually play a 
role in autoimmune processes is suggestive for the fart 
that autoreactivity in chronic inflamatory arthritis 
involves at least initially, cells recognizing epitopes 
of stress protein hsp 60. 
The immunodominant proteins of infecting microorganism 
are homologues of hsp in eukaryotes (Hedstrom et al., 
1987; Young et al., 1988). The evidence for the existence 
in SLE of a previously undescribed autoantibody to the 73 
kD constitutively expressed members of hsp 70 family is 
consistent with the concept of molecular mimicry as a 
mechanism of autoantibody induction in this disorder. 
Antibodies to members of hsp 90 family have been 
described in serum from patients suffering from systemic 
lupus erythematosus (SLE) (Minota et al. , 1988a). 
Stress antigens such as hsp 70 are also found to react 
with antibodies from these patients. Also autoantibodies 
to hsp 70 were detected in a minority of sera from 
patients with other rheumatic or viral diseases, but not 
in normal sera. (Minota et al., 1988b). However, recent 
studies have shown a similar frequency of anti hsp 70 
antibodies in patients with SLE and normal human subjects 
(Kindas-Mugge, 1993). Possibly this may be generated in the 
course of infections, since hsps are among the most 
dominant immunogens of infectious microorganism (Shinnick, 
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1991). The increased expression of endogenous hsp 
occurring during infection and inflammatory processes has 
been obseirved in peripheral blood cells from SLE patients 
(Deguchi, 1987; Norton, 1989; Deguchi, 1990) . Thus, the 
anti-hsp immune response could be elicited both by a 
foreign organism as well as by self components. Similar 
frequency of anti hsp 70 autoantibodies in SLE and normal 
subjects can not rule out the possibility that these 
autoantibodies may contribute to the complex pathogenesis of 
SLE at least in sub-groups of SLE patients. The elevated 
levels of IgA anti-hsp 70 antibodies reported by Tsoulfa 
et al. (1989), and the high titre of IgM antibodies 
measured in few of SLE patients (Kindas-Mugge, 1993) 
might indicate such relationship. Thus it can be imagined 
that the major disturbances of the immune network which 
occur in autoimmune diseases might also affect the anti-
hsp response which then could change from a mechanism of 
defence to mechanism of self destruction. 
Anti MT-hsp 65 antibodies have also been detected in 
sera of patients with systemic sclerosis (SSc) (Danieli et 
al., 1992) although its mechanism of induction still remains 
unanswered. The reaction of MT-hsp 65 can be viewed as 
the consequence of immunity against epitopes of human hsp 
65 which are shared by mycobacterial counterpart. The two 
molecules have 45% homology (Jindal et al. , 1989). The hsp 
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autoimmunity thus can be amplified during conditions 
leading to the synthesis of hsp in sufficient amount for 
T - cell activiation in the context of HLA-class II 
molecule. Ischemia, well documented in SLE, might 
represent the stress responsible for increased hsp 
expression (Polla, 1988). The correlation between anti 
hsp antibodies and disease activity in SSc as well as 
normal values in the group of SLE (Danieli et al. , 1992) 
are remarkable findings which indicate that the immune 
reaction is not a part of acute phase response but may be 
reflection of pathogenic mechanism. 
A recent study by Koga et al (1989) provides evidence 
that stressed host cell can serve as targets for T-cells 
against hsp 65. Although it is often assumed that only 
CD4''" T-cells are activated by intracellular bacteria, 
recent evidence suggests a role for CD8''' T-cells in these 
infections (Kaufmann, 1988) . This idea was supported 
by work of Rees et al. (1988), who isolated a CDB"^  T-cell 
line from the pleural effusions of tuberculosis patients 
that cross reacted with hsp 70 conjugates from M. 
tuberculosis. E.coli and humans. 
The general concept that can be formulated regarding 
the role of hsp in autoimmunity from the different 
findings are summarized as follows-
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(a) At least some T cells and antibodies against epitopes 
shared by bacterial and human hsp's have evaded 
tolerance mechanism and hence are present in many 
individual. 
(b) These T-cells and/or antibodies are activated during 
microbial infection by contact with microbial hsp's. 
(c) Self epitopes' of hsp's are expressed by host cells 
either alone or in the context of MHC molecules that 
suffer under certain stress conditions. 
(d) Recognition of these stressed host cells by T-cells 
and/or antibodies with specificity of shared epitope, 
trigger an autoimmune response. 
Objective of Present Study 
In the present study, attempts were made to probe the 
possible involvement of intracellular mycobacterial and heat 
shock proteins in the induction of human autoantibodies. 
The pathogenic strain of Mycobacterium tuberculosis (H-^ R^v) 
was cultured on Sauton's medium. The intracellular 
proteins from the bacilli were obtained by sonication. 
Gradient SDS-PAGE was employed in order to monitor the wide 
spectrum of intracellular proteins. The 70 kD heat shock 
protein of the Mycobacterium was detected by gradient SDS-
PAGE and isolated by electroelution. The immunological 
investigations were carried out by employing ELISA and 
Western blotting. The immunologic crossreactivity of 
19 
naturally occurring SLE anti-DNA autoantibodies with total 
mycobacterial sonicate (intracellular proteins) as well as 
70 kD heat shock protein was probed by ELISA. The binding 
of immuno-affinity purified anti-DNA antibodies with 70 kD 
heat shock protein was ascertained by employing Western 
blotting. 
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A. MATERIALS 
1. Chemicals 
Bovine serum albumin, calf thymus DNA, agarose, 
Coomassie brilliant blue R-250, ethidium bromide and anti-
human IgG alkaline phosphatase conjugate were purchased 
from Sigma Chemical Company, U.S.A. Polystyrene microtitre 
flat bottom ELISA plates having 96 wells (7 mm in 
diameter) were obtained from NUNC, Denmark. Tween 20, 
ammonium persulphate, acrylamide, bis-acrylamide, 
N,N,N,'N'- tetramethylethylene diamine were from Bio-Rad 
Laboratories U.S.A., Sephadex G-25, Sephadex G-200, 
Ficoll 400 were obtained from Pharmacia Fine Chemicals, 
Sweden. A colorigenic substrate para- nitrophenyl phosphate 
was obtained from C.S.I.R. Centre for Biochemicals, Delhi. 
Citric acid, magnesium sulphate, asparagine, dipotassium 
hydrogen phosphate, ferric ammonium citrate and glycerol 
were obtained from Qualigens, India. Sodium pyruvate was 
obtained from SRL, India. All other chemicals were of 
highest grade available. 
2. Equipments 
ELISA microplate reader MR-600 (Dynatech, U.S.A.), 
ELICO pH meter model Ll-lOT, Shimadzu spectrophotometer UV-
240, Slab gel electrophoresis (Bio-Rad Laboratories, 
U.S.A.) and Gradient mixer (Pharmacia Fine Chemicals, 
Sweden) and high speed refrigerated centrifuge (Avanti 30, 
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Beckmann, U.S.A.) and sonicator (Braun-Sonic, Melsunger, 
Germany) were the major equipments used in this study. 
B. METHODS 
1. Purification of DNA 
Calf thymus DNA was purified free of proteins and 
single stranded regions by the method of Ali et al., 
(1985). DNA solution (2 mg/ml) in O.lxSSC buffer (0.015 M 
sodium citrate, pH 7.3 containing 0.15 M sodium chloride) 
was mixed with equal volume of chloroform-isoamyl alcohol 
(24:1 ratio) in a stoppered glass cylinder. The cylinder 
was sealed and the contents were mixed end-to-end gently 
for one hour. The DNA in aqueous phase was separated from 
the organic layer and the extraction process was 
repeated. DNA was precipitated with two volumes of cold 
ethanol and were subsequently collected on a glass rod. 
The precipitate was air dried to remove traces of ethanol. 
The DNA was dissolved in 30 mM acetate buffer, pH 5.0 
containing 30 mM ZnCl2. The sample was then incubated with 
single strand specific enzyme, nuclease S-|^  (250 units/mg 
DNA) at 37°C for 30 minutes. The reaction was terminated 
by adding one tenth volume of 0.2 M EDTA, pH 8.0. The 
purified DNA was extracted thrice with chloroform -isoamyl 
alcohol and reprecipitated with cold ethanol. Finally the 
DNA was dried and dissolved in required buffer. 
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2. Determination of DNA concentration 
DNA was estimated by two methods 
(a) Colorimetric assay 
(b) Fluorimetric assay 
(a) Colorimetric estimation of DNA 
Colorimetric estimation of DNA was carried out 
according to Burton (1956) using diphenylamine reagent. 
(i) Diphenylamine reagent 
50 ml of glacial acetic acid was added to 750 mg of 
recrystallized diphenylamine. To this, 0.75 ml of 
concentrated sulphuric acid was added. The reagent was 
prepared fresh before use. 
(ii) Procedure 
To 1.0 ml of DNA sample (with varying concentration of 
DNA), 1.0 ml of 1 N perchloric acid was added and the tubes 
were incubated for 15 minutes in a water bath maintained 
at 70°C. To this 100 ul of 5.43 mM acetaldehyde was added 
followed by 2.0 ml diphenylamine reagent. The tubes were 
vortexed and then allowed to stand at room temperature for 
16-20 hrs for color development. Absorbance was monitored 
at 600 nm. The concentration of DNA in unknown sample was 
determined from the standard plot constructed with 
purified calf thymus DNA (Figure 1). 
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Figure 1. Standard plot for the 
estimation of DNA. 
colorimetric 
(b) Fluorimetric assay of DNA 
Fluorimetric estimation of DNA v;aE carried ou" 
according to Lebarca and Paigen (1979) using Hoechst dye, 
The Hoechst 33258 dye [C2-{2-(4 hydroxy - phenol )--:•-
benzimidazolyl-6(l-methyl-4 piperozyl)}) interacts with DNA 
with many fold increase in fluorescence. 
a) Reagents 
(i) 0.05 M sodium phosphate (pH 7.4) containing 0.002 
M EDTA and 2 M sodium chloride. 
(ii) 200 ug/ml of Hoechst 33258 in deionizea water. 
Working dye solution was prepared by diluting 
(ii) 200 fold in solution (i), when needed. 
b) Method 
0.1 - 1.0 lig of DNA in 0.1 ml final volume was mixed 
with 2.4 ml of working dye solution. The mixture was then 
incubated for 5 minutes at room temperature and the 
fluorescence was read at 460 nm. 
3. Determination of Protein Concentration 
Protein was estimated by the method of Lev ry et al. 
(1951) as described below. 
(a) Polin-Ciocalteu reagent 
The reagent was purchased from C.S.I.R. Centre for 
Biochemicals, Delhi. It was diluted to 1:4 with distilled 
water before use. 
(b) Alkaline copper reagent 
The composition of alkaline copper reagent were 
(i) 2.0 percent sodium carbonate in 0. IM sodium 
hydroxide. 
(ii) 0.5 percent copper sulphate in 1.0 percent sodium 
potassium tartrate. 
The working reagent was prepared fresh by mixing 
components (i) and (ii) in tl^ e ratio 50:1. 
(c) Procedure 
To 1.0 ml of protein samples were added 5 ml of 
alkaline copper reagent. The tubes were vortexed and 
allowed to stand at room temperature for 10 minutes. One ml 
of Folin-Ciocalteu reagent was added and the reaction was 
allowed to proceed for 3 0 minutes. Absorbance was monitored 
at 660 nm. Standard plot was constructed by using bovine 
serum albumin. From the standard plot the concentration of 
protein in unknown sample was determined (Figure 2 ) . 
4. Isolation of IgG 
Protein A - Sepharose is a popular and simple tool in 
the purification of IgG and its subclasses. Commercially 
obtained Protein A - Sepharose CL-4B (1.5 gm) was swelled 
in 0.01 M phosphate buffered saline (PBS), pH 7.4 at room 
temperature for 48-72 hr. The swelled gel (about 5.0 ml) 
was allowed to pack in a small column measuring 0.9 cm x 
15 cm by gravity sedimentation. The column was washed once 
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Figure 2. Standard plot for the coloritnetric 
estimation of protein. 
with 0.1 M sodium citrate, pH 3.0, to elute any previously 
bound material and then equilibrated with five volumes of 
PBS. Serum was diluted in an equal volume of PBS and 
passed through the column at a rate of 2 0 ml/hr. The 
unbound protein was eliminated by washing and the bound 
IgG was eluted with 0.58% acetic acid in 0.85% sodium 
chloride (Coding, 1976) . To prevent the effect of acidic pH 
of elution buffer on IgG , the eluate was collected in l ml 
of 1 M Tris-HCl, pH 8.5. The sample tubes were monitored 
at 280 nm and the concentration was determined by the 
relation, 1.4 O.D. 280 ^ -^'^ ^^ IgG/ml. 
5. Immunoaffinity Purification of IsmunogliLbulin G 
(a) CNBr activation of Sepharose 4B 
Fifteen millilitre of supplied Sepharose 4B was 
suspended in distilled water, filtered and washed with 300 
ml of cold distilled water on a sintered glass funnel ( 
porosity G-2). Moist gel (approximately 10 g) in 10 ml of 
2M sodium carbonate was kept in ice-NaCl bath kept on 
magnetic stirrer. To the gel was added one gram of cyanogen 
bromide in 0.8 ml acetonitrile with gentle stirring. The 
reaction product was filtered after 12 minutes on sintered 
glass funnel washed with 400 ml of cold 0.1 M sodium 
carbonate and resuspended in 10 ml of the same buffer. The 
unreacted CNBr (drained effluent) was reacted with 
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ferrous sulphate to convert it into harmless ferrocyanide. 
All steps were carried out in a fume-hood chamber (Ali et 
al., 1984). 
(b) Poly-L-lysine coupling to activated Sepharose 4B 
The method described by Wilcheck (1973) was followed. 
Immediately after CNBr activation of the gel an equal 
volume of poly-L-lysine (100 mg/10 ml of O.l M sodium 
carbonate) was added and kept at 4°C for 12 hr with slew 
stirring. The buffer was drained out, followed by washing 
with 100 ml each of cold (i) distilled water (ii) 0.1 N HCl 
(iii) 0.1 M sodium bicarbonate and (iv) distilled water 
till neutral. Finally, the gel was suspended in 40 ml of 
0.15 M acetate buffer, pH 4.5. The extent of poly-L-lysine 
depletion due to covalent coupling with activated Sepharose 
4B was quantified as described by Habeeb (1966) . 
(c) Inmunoaffinity purification of anti-DNA antibodies 
DNA-[polylysyl - Sepharose 4B] affinity column was 
prepared according to the method described earliier 
(Nicotra et al., 1982) with little modification. Twenty 
millilitre of polylysyl -Sepharose 4B was packed in a 
glass minicolumn (1.6 cm x 50 cm) and equilibrated with 
acetate buffer. Purified DNA (12.5 ml of 100 jjg/ml in 
acetate buffer) was loaded onto the gel and unbound 
material was washed with 50 ml of PBS, pH 7.4. Heat 
decomplemented SLE serum dialysed against PBS, diluted 
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to 1:10 and was passed through the column. The unbound 
antibodies were eliminated by washing and the bound 
proteins were eluted with a linear ionic strength 
gradient of 0.15 - 3.0 M sodium chloride in 0.01 M 
phosphate buffer, pH 7.4. Eluate was collected and monitored 
at 251 nm, 260 nm, 278 nm and 280 nm. The molar 
concentration of sodium chloride in fractions was 
evaluated by conductance measurements. 
d) Regeneration of affinity column 
The same column was regenerated several times by 
washing successively with 50 ml each of (i) distilled 
water (ii) 0.1 N HCl (iii) 0.1 M sodium bicarbonate and 
(iv) distilled water till neutral. 
6. Agarose Gel Electrophoresis of DNA 
(a) 1.0 percent agarose 
Agarose NA (1%) in 30 ml of TAE buffer, pH 8.0 was 
brought to molten state by boiling. The molten solution 
was allowed to cool to 50-60''C and was subsequently poured 
onto a horizontal gel tray of GNA -100 electrophoresis 
apparatus (Pharmacia, Sweden) and was left at room 
temperature for complete solidification. 
(b) Electrode buffer (TAE buffer) 
40 mM Tris-acetate and 2mM EDTA , pH 8.0 . 
(c) Saii^>le preparat ion 
The samples of less than 1 yg/ml in low ionic strength 
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were loaded into the wells. The sample contained one tenth 
volume of 30% Ficoll, 0.025% bromophenol blue, 0.5 M EDTA 
and 10 electrophoresis buffer. 
(d) Running conditions 
3 0 mA for 2 hours. 
(e) Staining 
The electrophoresed gel was stained with 
ethidium bromide (1 iig/ml) and the bands were 
visualised on a UV- transilluminator. 
7. Polyacrylamide Slah Gel Electrophoresis for Proteins 
Polyacrylamide slab gel electrophoresis was performed 
under denaturing conditions as described by Laemmli (1970). 
The following stock solutions were prepared. 
(i) Acrylamide-bisacrylamide (30:0.8) 
Thirty gram of acrylamide and 0.8 g bisacrylamide were 
dissolved in a total volume of 100 ml. The solution was 
mixed thoroughly, filtered and stored at 4"'C in an amber 
colored bottle to prevent photopolymerization. 
(ii) Resolving gel buffer - 3 M Tris-HCl, pH 8.8 
Stock solution was prepared by dissolving 3 6.3 gm 
Tris base in 48.0 ml of IN HCl. The contents were mixed 
properly and the pH was adjusted to 8.8. The final volume 
was brought to 100 ml. 
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(iii) Stacking gel buffer - 0.5 M Tris-HCl, pH 6.8 
To 40 ml of distilled water 6.05 gm of Tris base was 
dissolved. The pH was adjusted to 6.8 with 1 N HCl. The 
final volume was made up to 100 ml. 
(iv) Electrode buffer 
Tris ' glycine buffer (0.025 M and 0.192 M 
respectively), pH 8.3 containing 0.1 percent SDS. 
(v) Sample buffer 
6.0 gm Tris was dissolved in 80 ml of distilled water 
and the pH was adjusted to 6.8 with 0-phosphoric acid. 
Final volume was made up to 100 ml with distilled water. 
To 12.5 of above solution, 19 mg of bromophenol 
blue and 12 ml of glycerol was added. The contents were 
mixed thoroughly prior to use. 
(vi) Sample preparation 
Protein samples were mixed with sample buffer in the 
ratio of 4:1 (w/w). SDS was added to a final concentration 
of 2% and protein sample was boiled for 5 minutes prior to 
loading. 
(vii) Procedure 
Thoroughly washed glass plates (19 cm x 16 cm), 
separated by 1.0 mm thick spacer was sealed with 1% 
agarose. A 5-20% gradient gel was layered with 2.5% 
stacking gel according to recipe given below. 
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Recipe for 5-20% Gradient Gel (Total volume 24 ml) 
Solution 
Acrylamide-bisacrylamide 
Resolving gel buffer 
10% SDS 
1.5% ammonium 
persulphate 
Distilled water 
TEMED 6 jal 6 Ail 
5% 
2.0 ml 
1.5 ml 
120 yl 
600 jul 
7.774 ml 
20% 
8 .0 ml 
1.5 ml 
120 ul 
600 jal 
1.114 ml 
Recipe for 2.5% Stacking gel (Total volume 10 ml) 
Acrylamide - bisacrylamide 1.25 ml 
Stacking gel buffer 2.5 ml 
10% SDS 100 ul 
1.5% ammonium persulphate 500 yl 
Distilled water 5.65 ml 
TEMED 7.5 jul 
The reagents were mixed in the same order as is shown 
above and were poured into the gradient former. A 5-20% of 
the gradient gel was formed between the glass plates. The 
gel was then allowed to polymerize at room temperature. 
The protein samples were loaded into the wells and the 
electrophoresis was carried out for 6-8 hr at 70 Volts. The 
gel was stained overnight with Coomassie brilliant blue R 
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250. Destaining was carried out in a mixture of 10% 
acetic acid and 10% methanol. 
8. Enzyme Linked Immunosorbent Assay (ELISA) 
The presence of naturally occurring autoantibodies in 
the sera of patients with SLE against various nucleic 
acid and mycobacterial antigens were detected and 
quantitated by ELISA using polystyrene flat bottom 
microtiter plates as solid phase. The method described by 
Alam and Ali (1992) and Arif et al. (1994) was followed 
for the assay. 
(a) Buffers and Substrate 
(i) Tris buffered saline (TBS) 0.01 M Tris 
0.15 M NaCl 
pH 7.4 
(ii) Tris buffered saline-Tween-20 0.02 M Tris 
(TBS-T) 
0.144 M NaCl 
0.00268 M KCl 
Tween-20 -500 jjl/lit 
pH 7.4 
(iii Coating buffer 0.015 M sodium 
carbonate 
0.035 M sodium 
bicarbonate 
pH 9.6 
(iv) Substrate buffer 0.015 M sodium 
carbonate 
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0 .035 sodium 
bicarbonate 
pH 9.6 containing 
0.002 M 
magnesium chloride. 
(v) Substrate 500 xig p- nitrophenyl 
phosphate per ml of 
substrate buffer. 
(b) Procedure 
Polystyrene plate was coated with 100 ul of 
mycobacterial protein antigens (50 yig/ml) in carbonate-
bicarbonate buffer, pH 9.6 for two hours at room 
temperature followed by overnight incubation at 4°C. This 
was followed by washing the antigen immobilized plates 
thrice with TBS-T. The unoccupied sites were blocked by 
150 ul of 1.5% BSA in TBS for 5-6 hr. at room temperature. 
The plates were then coated with varying concentrations/ 
dilutions of antibody ( 100 jul) to be tested. The 
interaction was allowed to occur for 2 hr at room 
temperature followed by overnight incubation at 4°C. 
After extensive washing with TBS-T (4 times), the plates 
were coated with anti-human IgG alkaline phosphatase 
conjugate and the reaction was allowed to proceed for 2 
hr at room temperature. Finally, after washing the plates 
with TBS-T (4 times), a colorigenic substrate namely p-
nitrophenyl phosphate was added to each well (100 uD • 
After proper color development at 37°C, absorbance of 
each well was monitored at 410 nm on a Dynatech ELISA 
35 
Microplate Reader. Each sample was coated in duplicate 
and the results were expressed as a mean of ^test" 
^control• 
For nucleic acid antigens, polystyrene plates were 
precoated with 100 jal of poly D-lysine solution (50 jug/ml 
in distilled water) in order to increase antigen 
immobilization. The plates were washed thrice with TBS to 
eliminate the unadsorbed bridging molecule and were coated 
with nucleic acid antigens (100 jul of 2.5 iig/ml stock in 
TBS). The reaction was allowed to proceed for 2 hr at 
room temperature, followed by overnight incubation at 4°C. 
The antigen coated plates were washed thrice with TBS-T and 
coated with 100 jul/well of poly-L-glutamate (50 ug/ml in 
TBS) for 2 hr at room temperature. The plates were 
subjected to washing and the rest of the steps followed 
were exactly the same as described above. 
9. Competition ELISA 
The specificity of naturally occurring SLE 
autoantibodies against nucleic acid and mycobacterial 
antigens was investigated by competition inhibition 
experiments. For the assay, varying concentrations of 
competitors were interacted with antibody (serum or purified 
IgG) at 37°C for 2 hr followed by overnight incubation at 
4°C. The reaction resulted in the formation of immune 
36 
complex (IC) which was ultimately used in ELISA instead 
of serum. The inhibition of antigen binding in presence of 
various inhibitors (competitors) was determined by 
measuring their ability to reduce the resulting absorbance 
relative to control assay lacking competitors. The results 
were expressed as percent inhibition. 
10. lamimodif fusion 
Ouchterlony double diffusion method was employed for 
carrying out precipitin reactions, using glass petri 
dishes, (Tan et al., 1966). Agarose (0.4 percent) solution 
was prepared in PBS containing 0.1 percent sodium azide. 
Six millitre of this molten mixture was poured onto a 5 cm 
X 1.5 cm glass petri dishe. The dishes were allowed to 
harden at room temperature and stored at 4°C. All sera 
were decomplemented by heating at 56°C for 30 minutes. 
Fifty microlitre each of serum and antigen was placed m 
the wells and the reaction was allowed to proceed for 72 
hr in a moist chamber at room temperature. Petri dishes 
were flooded with 5 percent sodium citrate to remove non-
specific precipitin lines. The antigen-antibody precipitin 
lines were analysed visually and results recorded. 
11. Coxinter Ixamxinoelectrophoresis 
Three millilitres of the molten agarose in 25 mM 
barbital buffer, pH 8.4 was pipetted onto alcohol cleaned 
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microscopic slides measuring 7.5 cm x 2.5 cm. The gel was 
allowed to solidify at room temperature. Wells measuring 
4 mm in diameter were made at a distance of 5 mm between 
the two opposite wells. Antigens were placed in the 
cathodal well, whereas the decomplemented serum in the 
anodal wells (25 ul in each wells). Electrophoresis was 
performed for 45-60 minutes in 50 mM barbital buffer, pH 
8.4 with a current of 3 mA per slide. The slides were 
washed with 5 percent sodium citrate to remove the non-
specific precipitin lines. 
12. Isolation of Mycobacterial Antigen 
(a) Organism 
Mycobacterium tuberculosis H2-7Rv strain was obtained 
from All India Institute of Medical Sciences, New Delhi by 
passage on Lowenstein-Jensen medium. 
(b) Mediiun 
Modified Sauton's medium was used to culture the 
pathogenic strain. The composition of the medium was as 
follows. 
Asparagine 4.0 gm 
Citric acid 2.0 gm 
Magnesium sulphate 0.5 gm 
Dipotassium hydrogen 0.5 gm 
phosphate 
Ferric ammonium citrate 0.05 gm 
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Glycerol 35 ml 
Sodium pyruvate 05 mg 
The above components were dissolved serially and the 
final volume was made upto one litre with distilled 
water. The pH was adjusted to 7.4 by addition of dilute 
ammonium hydroxide solution. The medium was distributed in 
4-5 one litre conical flasks (200 ml in each flask) and 
were subsequently autoclaved at 120°C for 30 minutes. 
(c) Procedure 
The culture media was inoculated with H-^ R^v strain and 
was allowed to grow at 37°C for 10-12 days. The culture 
was then heat killed at 100°C for 75 minutes and were 
harvested by centrifugation at 10,000 rpm for 30 minutes at 
4°C. The supernatant (MTCF) was then separated from the 
pellet (bacilli). 
13. Steilization of Antigens in Mycobacterium tuberculosis 
Culture Filtrate 
The supernatant was sterlized by filtration through a 
0.45u pore size membrane (Millipore Corp. U.S.A.). The 
Mycobacterium tuberculosis culture filtrate (MTCF) was 
fifty fold concentrated and passed through gel 
filtration PD-10 column (containing G-25) for 
desalting. The MTCF was then stored at -70°C in smal 
aliquots. 
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14. Liberation of Intracellular Proteins from Heat Killed 
H37RV Bacilli by Sonication 
Heat killed bacilli (pellet) were suspended in 
sonicating buffer containing 1 tnM DTT (dithiothreitol) , 1 
mM PMSF and 50 ul of beta-tnercaptoethanol in Tris 
buffered saline, pH 7.4). The cell walls of bacilli were 
disrupted in ice-cold bath by sonication for 15 minutes. 
The process was repeated thrice at an interval of 5 
minutes. The sonicated bacilli was microcentrifuged at 
20,000 X g for 5-10 minutes. The protein content of the 
supernatant (sonic extract) was determined colorimetrically 
as described earlier using bovine serum albumin as 
standard. The sonic extract containing a wide spectrum of 
mycobacterial protein antigens was stored in aliguots at -
20°C for further study. 
15. Electroelution 
The 70 kD heat shock protein antigen appearing in the 
gradient SDS-PAGE was carefully sliced off and were 
separately isolated from the gel by electrophoretically 
transferring the protein bands from the gel in an 
electroelution chamber equipped with BT-1 and BT-2 
membranes (Bio-Rad). The elution was carried out at 150 
volts for 5 hr at room temperature. The transfer buffer 
used was TBS containing 20% methanol (150 mM Tris-HCl,l75 
mM NaCl, pH 7.4). The electroeluted proteins were dialyzed 
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against MQ water, lyophilized and stored at -20''C. 
16. Western Blotting 
The electrophoresed proteins on the gradient gel was 
transferred onto nitrocellulose membranes (Bio-Rad) 
according to the method of Towbin et al. (1979). Transfer 
of proteins from the gel to the NC membranes was 
accomplished on a Bio-Rad Protean II transfer cell at 80 
volts. The ingredients of transfer buffer were 25 mM Tris 
base, 192 mM glycine, 20% (v/v) methanol and 0.002% SDS, pH 
8.3 . The complete transfer of proteins to the membranes 
was checked by staining a strip by Amido Black. 
Thereafter, the protein loaded membrane was treated with 1% 
BSA in TBS-T (w/v) in order to saturate the binding sites 
on NC membrane. Saturation was accomplished at 4°C 
overnight. The saturated membranes were treated with 
affinity purified anti-DNA antibodies and the reaction was 
allowed to proceed for 2 hr at room temperature followed 
by overnight incubation at 4°C. Thereafter, the NC 
membranes were washed with TBS-T for four times where the 
duration between each wash was 10 minutes. The bound 
antibodies were then detected by treating the NC membranes 
with anti-human IgG conjugated to horse-radish peroxidase 
(1:1500 dilution in TBS) for 1 hr at room temperature. 
Unbound conjugate was removed by washing the NC membranes 
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with TBS-T for five times, followed by a final wash with 
distilled water. The colour was developed by treating the 
NC membranes with the substrate (12 mg 4-chloro-l-naphthol 
dissolved in 4 ml methanol, 20 ml TBS, 40 )J1 H2O2) in dark. 
After colour development, the membranes were washed with 
water, dried and photographed. 
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The presence of autoantibodies to self antigens 
including nucleic acids have been detected in sera of 
pateints with systemic lupus erythematosus (SLE) (Tan, 
1989; Alam and Ali, 1992). 
In the present study attempts have been made to probe 
the binding of SLE autoantibodies against intracellular 
protein antigen(s) of Mycobacterium tuberculosis (H^^Rv). 
The autoantibodies were characterized by direct binding 
ELISA, competition ELISA, band shift assay and Western 
blot. 
Sera of various patients with SLE as well as of normal 
humans were tested for the presence of anti-DNA antibodies 
by CIE and ID. Both the techniques failed to detect 
precipitating anti-DNA antibodies. Among the various SLE 
sera tested by direct binding ELISA, only those exhibiting 
a titer greater than 1:6400 were opted for further studies 
(Figs. 3 and 4). 
The selected SLE sera exhibiting high titer anti-DNA 
antibodies were further subjected to antigenic specificity 
study by employing competition-inhibition ELISA. With 
native DNA as an inhibitor, the competition results showed a 
maximum of 70 percent inhibition (Fig. 5) in the antibody 
binding at a maximum inhibitor concentration of 10 jjg/ml . 
Fifty percent elimination in the autoantibody binding was 
recorded at an inhibitor concentration of 2 xig/ml . As 
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Figure 3. Direct binding ELISA of SLE serum. The microtiter 
plates were coated with native DNA (2.5 ug/ml). 
( -•- ) SLE serum 1 , ( - ^ ) SLE serum 2 
( -Q- ) SLE serum 3 , ( <D- ) Normal human sera 
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Figure 4. Direct binding ELISA of SLE serum. 
( - O ) SLE serum 4 
{ -#- ) SLE serum 6 
) SLE serum 5 
-<I^  ) Normal human sera 
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Figure 5 Inhibition ELISA of SLE anti-DNA antibodies. The 
microtiter plate was coated with native DNA (2.5 jjg/ml). The 
competitors were Native DNA ( -•- ) , ssDNA ( -^ O- ) and RNA 
4G 
evident from the binding data (Fig. 5) , althougr. heat.. 
denatured DNA (SFDNA) when employed as an inhibitor 
exhibited the same magnitude of binding as was observed with 
the native DNA. However, the amount of inhibitor required 
to eliminate fifty percent antibody binding was reduced 
considerably. In this case, fifty percent inhibition was 
recorded at an inhibitor concentration of 0.2 yg/ml. Thus 
the result indicates that the SLE sera opted for our study 
had autoantibodies which were 10-fold more specific for 
ssDNA than for native DNA, as judged on the basis of 50 
percent inhibition. In contrast to native DNA and ssDNA, 
RNA was found to be non-inihibiting (Fig. 5). 
Intracellular proteins synthesized by the pathogenic 
strain H^yRv. of Mycobacterium tuberculosis were employed 
as antigens to probe the possible role of environmental 
infectious agents in autoantibody production in SLE. 
Mycobacterium tuberculosis (H2yRv) cultured on Sauton's 
medium was heat killed, harvested and subsequently the 
pelleted cells were suspended in sonicating buffer. 
Intracellular proteins from the bacilli (pellets) were 
liberated by sonication. 
Prior to the binding studies against intracellular 
mycobacterial protein antigen{s), attempts were also made 
to probe the binding of SLE autoantibodies with total 
intact heat killed mycobacterial bacilli (unsonicated). 
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This was done in order to check the possible involvement of 
some proteins present on the outer surface of bacilli in 
anti-DNA antibody recognition. Plates coated with intact 
heat killed bacilli showed negligible binding with SLE 
anti-DNA autoantibodies (Fig. 6). As evident from the data 
, non-significant titer of 1:100 was observed. On the other 
hand, appreciably high binding was observed with the total 
mycobacterial sonicate (Fig. 7). No binding was observed 
with normal human sera. The specificity of SLE sera 
against total bacterial sonicate was checked by 
inhibition ELISA. A maximum of 80 percent inhibition in 
the antibody binding was observed at a maximum inhibitor 
concentration of 30 ug/ml. Fifty percent inhibition in 
the antibody activity was recorded at an inhibitor 
concentration of 4 ug/ml (Fig. 8). 
Since apart from the intracellular proteins, the 
total mycobacterial sonicate (without centrifugation) 
employed in the above inhibition experiment possess 
mycobacterial DNA attached to the completely ruptured or 
sonicated bacilli as demonstrated by fluorimetric (Hoechst 
dye assay) as well as agarose gel electrophoresis (Fig. 9). 
Attempts were made to separate intracellular proteins from 
the sonicated bacilli. Microcentrifugation at high speed 
of the total sonicate yielded an extract referred to as 
Mycobacterium tuberculosis sonic extract (MTSE). 
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Figure 6. Direct binding ELISA of SLE anti-DNA antibodies. The 
microtiter plate was coated with heat killed bacilli 
(50 xjg/ml) . 
( -C- ) SLE serum 
( -#- ) Normal human sera 
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Figure 7. Direct binding ELISA of SLE anti-DNA antibodies. The 
microtiter plate was coated with total mycobacterial 
sonicate (50 iig/ml) . 
( -O- ) SLE serum 1, ( 
( -0- ) Normal human sera 
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Figure 8. Inhibition ELISA of SLE antibodies binding 
with total mycobacterial sonicate. The 
microtiter plate was coated with total 
mycobacterial sonicate (50 ng/ml). 
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Figure 9. Agarose gel electrophoresis of intracellular 
secreted mycobacterial proteins. 
and 
Lane 1 - native DNA 
Lane 2 - sonicated bacilli 
Lane 3 - secreted proteins 
52 
Colorimetrie determinations of DNA by diphenylamine reagent 
were negative with MTSE, thereby indicating the absence of 
DNA in the mycobacterial sonic extract. Direct binding 
ELISA on microtiter plate coated with the DNA-free MTSE 
exhibited high binding with anti-DNA antibodies (Fig.10). 
When employed as inhibitor in competition ELISA, as 
illustrated in figure 11, a maximum of 82 percent inhibition 
in the antibody binding was observed at a maximum inhibitor 
concentration of 30 ug/ml. Fifty percent elimination in 
the antibody binding was recorded at an inhibitor 
concentration of 3.4 ug/ml. 
The IgG was isolated from SLE serum by employing 
Protein A-Sepahrose column chromatography (Fig. 12). The 
homogeneous character of the isolated IgG was 
ascertained by polyacrylamide gel electrophoresis (Fig. 
13). The electrophoretically pure IgG was used for further 
studies. Direct binding ELISA on plates coated with sonic 
extracts (MTSE) showed nearly the same magnitude of binding 
with SLE IgG as was observed with the serum (Fig. 14). 
With the sonic extract (MTSE), inhibition curves showed a 
maximum inhibition of 84 percent in the SLE autoantibody 
(IgG) binding (Fig. 15). As evident from the binding data 
(Fig. 15), fifty percent elimination in the antibody binding 
was recorded at an inhibitor concentration of 1.2 jag/ml. 
The results indicate the high specificity of SLE IgG for 
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Figure 10. Direct binding ELISA of SLE anti- DNA 
The microtiter plates were coated 
(50 Jig/ml) . 
( -•- ) SLE serum 
( -o- ) Normal human sera 
antibodies. 
with MTSE 
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Figure 11. Inhibition ELISA of SLE anti-DNA antibody 
binding with MTSE. The microtiter plate was 
coated with MTSE (50 jug/ml) . 
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Figure 12. Elution profile of SLE IgG by Protein A-
Sepharose column. High titer anti-DNA 
antibodies were applied onto the column and 
bound material was eluted with 0.58 percent 
acetic acid in 0.85 percent sodium 
chloride. Fractions of 3 ml each were 
collected in l ml of l M Tris-HCl, pH 8.5. 
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Figure 13. SDS-polyacrylamide gel electrophoresis of purified 
SLE IgG. 
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Figure 14. Direct binding ELISA of protein A-Sepharose 
purified SLE IgG with MTSE. The microtiter plate 
was coated with MTSE (50 jag/ml) . 
( -0- ) SLE IgG 
( —'^>~ ) Normal human IgG. 
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Figure 15. Inhibition ELISA of purified SLE IgG with MTSE. 
The microtiter plate was coated with MTSE (50 
ug/ml). 
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the protein antigens in MTSE. 
Mycobacterial 70 kD heat shock protein (hsp 70) was 
isolated from the sonicated bacilli of Mycobacterium 
tuberculosis (H37RV) by electroelution from an 
electrophoresed 5-20% gradient SDS-polyacrylamide gel. 
The results of gradients SDS-PAGE for sonicated bacilli as 
well as of the electroeluted 70 kD heat shock protein are 
depicted in Fig. 16a and 16b respectively. The 
electroeluted mycobacterial hsp 70 kD was employed in ELISA 
as well as Western blotting. Direct binding ELISA with 
plates coated with hsp 70 kD exhibited a binding of high 
magnitude by protein A-Sepharose isolated SLE IgG (Fig. 
17). Once again, the binding of normal human IgG was of 
very low magnitude (Fig. 17). The inhibition studies 
(Fig. 18) revealed a maximum of 88 percent inhibition in 
the SLE IgG binding with hsp 70 kD at a maximum inhibitor 
concentration of 20 ug/ml. Only 0.8 ug/ml of inhibitor 
(hsp 70 kD) was required to eliminate fifty percent of SLE 
IgG activity (Fig. 18). The results thus indicate the 
high specificity of SLE IgG towards mycobacterial 70 kD 
heat shock protein. The binding characteristics of the 
SLE autoantibodies against various nucleic acids and 
mycobacterial antigens are given in Table 1. 
In order to substantiate the above results, Western 
blot assay was also carried out so as to probe the 
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Figure 16 (a)SDS-PAGE of total mycobacterial sonicate on 5-20 
percent gradient gel (b) SDS-PAGE of electroeluted 70 
kD heat shock protein on 5-20 percent gradient gel. 
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Figure 17. Direct binding ELISA of protein A-Sepharose 
purified SLE IgG on plate coated with hsp 70 kD. 
( -C>- ) SLE serum, ( 
( -3 ) Normal human IgG 
) SLE IgG and 
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Figure 18. Compet i t ion immunoassay of SLE anti-DNA 
an t ibody by hsp 70 kD on p l a t e coa ted with hsp 
70 kD. 
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Table - 1 
Competition Inhibition Data of various inhibitors with SLE 
seriun and its isolated IgG. 
Source of Inhibitor Inhibitor 
antibody concentration 
(jug/ml) 
Concentration 
for 50% 
inhibition 
(iig/ml) 
2 
0.2 
-
4.0 
3.4 
1.2 
0.8 
Maximum 
inhibitior 
( % ) 
69 
70 
15 
80 
82 
84 
88 
SLE serum dsDNA 
SSDNA 
RNA 
total 
sonicate 
MTSE 
SLE IgG MTSE 
hsp 70 
0 • 
0 • 
0 • 
0 • 
0 -
0 -
0 -
- 10 
- 15 
- 10 
- 30 
- 30 
• 25 
• 20 
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iramunointeraction of SLE IgG with mycobacterial 70 kD heat 
shock protein. Prior to Western blot analysis, SLE IgG was 
subjected to immunoaffinity purification on a column of 
DNA linked to polylysyl-Sepharose 4B matrix (Fig. 19). The 
above affinity purified SLE IgG on DNA-matrix was employed 
in Western blot analysis. The results depicted in Figure 
20 indicated the strong . antigen-antibody interaction 
undergone between 70 kD heat shock protein and 
immunoaffinity purified SLE IgG. 
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Figure 19. Immunoaffinity purification of anti-DNA 
antibodies on DNA- [polylysyl - Sepharose 4B] 
column. Anti-DNA positive SLE serum was 
passed through the column and bound material 
was eluted with linear ionic strength 
gradient { ) of sodium chloride (0.15 
to 3 M) in 0.01 M sodium phosphate buffer, pH 
7.4. 
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Figure 20. Western blotting of hsp 70 kD with affinity 
purified SLE IgG. 
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Systemic lupus erythematosus (SLE) is an autoimmune 
disease of unknown etiology characterized by the presence 
of heterogenous population of circulating antibodies of 
intracellular proteins and nucleic acids. These 
autoantibodies have specificities for nucleic acids (RNA and 
DNA), histones and ribonucleoproteins (Tan, 1989). There 
are also evidences that anti-DNA antibodies cross react 
with epitopes on infectious agents and that anti- DNA 
antibodies may be very similar in structure to anti-
bacterial antibodies. (Hahn and Tsao, 1993). Questions 
about the mechanism leading to the formation of anti-DNA 
antibodies in SLE, their specificity as well as their 
relationship with antibodies directed towards other self 
constituents is still unsolved (Harley and Scofield, 1991; 
Brendel et al., 1991). In view of its poor 
immunogenicity native DNA is unlikely to be involved in SLE 
pathogenesis (Pisetsky et al., 1990). Thus, some other 
structure appears to be the trigger of autoantibody 
production whereas DNA might only be a crossreactive 
antigen. These structures include DNA modified with drugs, 
reactive oxygen species, nucleic acids of bacterial 
origin, DNA-psoralen crosslinks, B-estradiol linked DNA and 
Poly (lysine- glutamate) complexes (Caroll et al. , 1985,-
Hasan et al., 1991; Ara et al., 1993; Alam et al., 1993; 
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Moinuddin and Ali, 1994; Arif et al., 1994). Native DNA IE 
no longer regarded as the antigen initiating the disease 
mainly because immunization with native DNA does not induce 
SLE like symtoms. 
The possible association of Mycobacterium tuberculosis 
and human autoimmune diseases have been indicated (Mclean 
et al., 1990) but their role in its pathogenesis is not yet 
clear. Recent studies indicate the possible involvement 
of mycobacterial heat shock proteins (hsps) acting as 
antigens for autoantibody production. (Winfield and 
Jarjour, 1991). Because infection entails " stress" for 
both the microorganism and the host (Buchmeier and 
Hefron, 1990) increased synthesis and altered expression 
of extremely similar sets of autologous and highly 
immunogenic foreign molecules occur during times of active 
immune responses. Mechanistically, therefore, infection 
would appear to be an ideal stimulus for the emergence of 
autoreactive T-cell and B-cell responses against host 
stress proteins. 
In the present study attempts have been made to probe 
the binding of SLE anti-DNA autoantibodies with 
mycobacterial intracellular proteins as well as 70 kD heat 
shock protein synthesized by Mycobacterium tuberculosis 
(H37RV). The binding studies would help in elucidating the 
possible involvement of heat shock proteins in the 
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aucoantibody production in SLE. Sera of SLE patients 
were assayed for anti-DNA antibodies by eraployinc enz>^ ie 
linked immunosorbent assay (ELIS?.) . The 
immunocrossreactivity of SLS aatoantibcdies against 
mycobacterial heat shock proteins was analysed by ELISr, and 
Western blotting. The selected SLE sera exhibiting high 
titer anti-DNA antibodies as revealed by direct binding 
ELISA were further subjected to specificity ascertation by 
employing competicion inhibition ELISA. Tlje inhibition 
ELISA results revealed for the presence of a greater 
magnitude of ssDNA specific autoantibodies in r.ho opted SLE 
sera in comparison to native DNA. Thus, the binding data 
is suggestive for the presence of ten fold more specific 
autoantibodies direc ed against secondary structure than 
against the negatively charged backrone. 
Anti-DNA antibodies have been found to cross react vnth 
memibrane associated proteins (Jacob et al. , 1984) . Thus 
prior to binding studies, attempts were also made to i. robe 
the binding of SLE autoantibodies with total intact heat 
killed mycobacterial bacilli. This was done in order to 
check the possible involvement of some proteinr present on 
the outer surface of mycobacterial bacilli in the 
interaction process. The binding results obtarned with 
intact bacilli were found to be n-.gative, thereby omitting 
the possibility of bacilli surface antiaens in the 
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interaction process. After ascertaining the non-reactivity 
of SLE autoantibodies towards bacilli surface protein(s), 
attempts were made to probe the binding with intracellular 
mycobacterial proteins. Thus, the heat killed intact bacilli 
were ruptured by sonication in order to liberate the 
intracellular proteins. Interestingly, the binding data 
showed the SLE autoantibodies to possess a remarkably high 
specificity for intracellular mycobacterial proteins present 
in the total sonicate. The binding results are thus 
suggestive for the presence of autoantibodies in SLE sera to 
possess immunoreactivity towards intracellular proteins and 
not towards mycobacterial surface protein(s). 
However, apart from intracellular protein(s), the total 
mycobacterial sonicate possess mycobacterial DNA attached 
to the sonicated bacilli. Therefore, the tota. sonicate 
was microfuged at high speed in order to separate the 
intracellular proteins from DNA. The mycobacterium 
tuberculosis sonic extract (MTSE) resulted as a 
consequence of microfugation of the total sonicate was 
found to be negative for DNA as demonstrated by 
fluorimetric estimation and agarose gel electrophoresis 
followed by staining with ethidium bromide. The MTSE so 
produced having exlusively intracellular proteins was 
employed in further binding studies. The competition-
inhibition studies exhibiting a remarkably high binding 
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with MTSE is further supportive for the above argument 
that SLE autoantibodies possess appreciable 
itnmunoreactivity towards mycobacterial intracellular 
protein(s). The same magnitude of binding was observed 
with isolated SLE IgG thereby indicating the high 
specificity of SLE IgG for intracellular protein antigens 
in MTSE. 
The 70 kD family of heat shock proteins is one of the 
most prominent classes of heat shock proteins. A large 
portion of the immune response to infecting mycobacteria 
appear to be directed at two particular proteins mainly 
70 kD and 65 kD. (Shinnick et al., 1988). Therefore, in 
the light of the above view, hsp 70 kD was isolated from 
the sonicated bacilli of Mycobacterium tuberculosis(HT^RV). 
The 70 kD protein showed high magnitude of binding with 
Protein-A Sepharose isolated IgG. High specificity of SLE 
IgG towards hsp 70 is evident from the inhibition ELISA 
results. Further evidence for the anti-DNA-hsp 70 kD 
interaction was obtained by Western blotting by employing 
immunoaffinity purified anti-DNA IgG. The strong 
recognition of affinity purified anti-DNA IgG with hsp 70 
kD further strengthens the above observations. These 
observations are important in view of the multifactorial 
pathogenesis of human SLE (Wick et al., 1987). The 
retention of crossreactivity of autoantibodies with hsp 70 
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}cD and mycobacterial sonic extract after immunoaffmity 
purification further augments the idea of an alternate 
antigen for the induction of autoantibodies cross reactive 
with native DNA. Since mankind is quite susceptible to 
mycobacterial infection, the possible involvement of 
mycobacterial antigen(s) (hsp or non hsp) in SLE 
autoantibody induction can be inferred from our 
observations. Thus, the role of intracellular mycobacterial 
protein antigen(s) in the pathogenesis of SLE needs further 
investigation. 
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